Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cellular thiol system refers to the integrated network of small-molecule and protein thiols (including but not limited to glutathione, cysteine residues, coenzyme A, thioredoxin, and glutaredoxin systems) responsible for maintaining intracellular redox equilibrium. These systems act as electron donors/acceptors, facilitate antioxidant defense, regulate protein folding via disulfide bond formation and breakage, and enable post-translational modifications that control signaling and gene regulation. The thiol system is not a discrete therapeutic target but rather a biological framework fundamental to cell survival, stress response, and signaling. Defects or imbalances in thiol systems have been implicated in multiple diseases, including cancer, cardiovascular, neurodegenerative, and inflammatory conditions.
Restoration or depletion of intracellular thiols; Reversal of protein S-glutathionylation; Enhancement or inhibition of antioxidant capacity
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular thiol system.